This is not the first joint project, the information has already been distributed in November 2014 that its staff have successfully recreated the liver tissue. Printed using the 3D-biopechati liver retained their viability for 40 days. Its mission - to participate in the testing of drugs. Pharmaceutical companies are testing drugs on this material before releasing them on the market. Printed on bioprinter Organovo liver tissue produced in commercial production, the company's customers can conduct research in the laboratory Organovo and under the supervision of its expert. While such synthetic fabric is not suitable for human transplantation, but work on this is underway. The company plans to create tissue for transplant in the next five years. Printed kidney tissue has the same purpose as already "mastered" Organovo liver tissue. This material will also be tested medicines. Implementation of this project will accelerate the creation of medicines for people with diseased kidneys. In the US alone there are more than 25 million patients with various diseases of these organs.



Kidney printed Organovo, home to more than two weeks, in contrast to the current designs available, which are already used in their practice pharmaceutical companies. Now the testing of drugs is carried out on the kidney tissue which can survive one to two days. Typically monolayer is prepared from kidney cell cultures. In tissues that are printed on the new technology, dubbed exVive3D tissue, it can be carried out more research. When you create liver and kidney tissue was used Organovo proprietary system - NovoGen. The company expects the commercial use of kidney tissue, it will happen in the second half of 2016.